In this seminar, Sandesh C.S. Nagamani, M.D., talks about a 2014 paper published in The Journal of Clinical Investigation titled "Evaluation of teriparatide treatment in adults with osteogenesis imperfecta." The paper describes the largest placebo-controlled, randomized clinical trial in adults with osteogenesis imperfecta (OI), which also happened to be the first OI trial to involve the use of anabolic agents.
Link to research paper: www.jci.org/articles/view/71101
Speaker:
Sandesh C.S. Nagamani, M.D., Baylor College of Medicine
Moderators:
Christopher Ours, M.D., National Human Genome Research Institute
Oleg Shchelochkov, M.D., FAAP, DABMG, National Human Genome Research Institute
The Excellence in Clinical Research Seminar Series is designed to facilitate clinical research in the rare disease space with a focus on regulatory medicine and clinical trials in Mendelian disorders. The series will follow one of two formats: (1) a journal club joined by one of the leading authors on a peer-reviewed publication or (2) an interview with a leader in regulatory medicine and clinical trials.
About the Seminar Series: www.genome.gov/event-calendar/Excellence_in_Clinical_Research_Seminar_Series
2 ноя 2021
